HF
PHIO icon

HRT Financial’s Phio Pharmaceuticals PHIO Stock Holding History

HRT Financial’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Sell
13,182
-21,550
-62% -$24.6K ﹤0.01% 3966
2026
Q1 		$42K Buy
+34,732
New +$39.6K ﹤0.01% 3472
2025
Q1 		– Sell
-42,338
Closed -$76K – 3196
2024
Q4 		$76K Buy
+42,338
New +$115K ﹤0.01% 2074
2022
Q4 		– Sell
-169
Closed -$10K – 2978
2022
Q3 		$10K Buy
+169
New +$12.8K ﹤0.01% 2537

Other funds holding PHIO

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial's PHIO Position: Q2 2026 in Review

HRT Financial reduced its Phio Pharmaceuticals (PHIO) stake by 62% in Q2 2026, selling an estimated $24.6K and leaving 13,182 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

HRT Financial first reported a position in PHIO in Q3 2022 and has held it in 4 quarters since. The position peaked at $76K in Q4 2024. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • HRT Financial held 13,182 shares of Phio Pharmaceuticals worth $13K as of Q2 2026.
  • HRT Financial sold 21,550 Phio Pharmaceuticals shares in Q2 2026, an estimated $24.6K.
  • Phio Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3966 holding.
  • HRT Financial first reported a position in Phio Pharmaceuticals in Q3 2022 and has held it in 4 quarters since.
  • HRT Financial's Phio Pharmaceuticals position peaked at $76K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.